Agnese Secondo Selected Research

Therapeutics

10/2020

Modulation of Cerebral Store-operated Calcium Entry-regulatory Factor (SARAF) and Peripheral Orai1 Following Focal Cerebral Ischemia and Preconditioning in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Agnese Secondo Research Topics

Disease

8	Brain Ischemia (Cerebral Ischemia) 10/2020 - 01/2008
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2014
6	Stroke (Strokes) 01/2022 - 01/2013
6	Hypoxia (Hypoxemia) 01/2020 - 03/2007
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 08/2012
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019 - 11/2009
5	Infarction (Infarctions) 08/2015 - 03/2004
5	Neuroblastoma 01/2015 - 11/2004
4	Neoplasms (Cancer) 01/2018 - 12/2011
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2022 - 10/2019
2	Dementia (Dementias) 12/2022 - 01/2019
2	Nervous System Diseases (Neurological Disorders) 01/2020 - 04/2003
2	Down Syndrome (Down's Syndrome) 01/2020 - 01/2019
2	Inflammation (Inflammations) 01/2019 - 04/2016
2	Celiac Disease (Celiac Sprue) 01/2013 - 01/2012
1	Neuroinflammatory Diseases 01/2022
1	Insulin Resistance 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2021
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2020
1	Multiple Sclerosis 01/2020
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2019
1	Demyelinating Diseases (Demyelinating Disease) 01/2019
1	Schizophrenia (Dementia Praecox) 01/2019
1	Gliosis 12/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2018
1	Vascular Remodeling 04/2016
1	Lung Neoplasms (Lung Cancer) 04/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2015
1	Lymphatic Metastasis 03/2014
1	Thyroid Neoplasms (Thyroid Cancer) 03/2014
1	medullary Thyroid cancer 03/2014
1	Memory Disorders (Memory Loss) 01/2013
1	Colorectal Neoplasms (Colorectal Cancer) 12/2011

Drug/Important Bio-Agent (IBA)

10	CalciumIBA 01/2022 - 11/2004
8	Protein Isoforms (Isoforms)IBA 01/2020 - 03/2007
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2003
5	Sodium-Calcium ExchangerIBA 03/2016 - 03/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2013
3	Oxygen (Dioxygen)IBA 01/2019 - 02/2013
3	Chlorodiphenyl (54% Chlorine)IBA 01/2015 - 08/2006
3	Polychlorinated Biphenyls (PCBs)IBA 01/2015 - 08/2006
3	Adenosine Triphosphate (ATP)IBA 12/2007 - 05/2005
2	beta-N-methylamino-L-alanine (beta-methylamino-L-alanine)IBA 12/2022 - 01/2019
2	PolyphenolsIBA 01/2022 - 11/2015
2	Peptides (Polypeptides)IBA 01/2022 - 08/2012
2	Neuroprotective AgentsIBA 01/2022 - 01/2013
2	IonsIBA 01/2021 - 02/2013
2	Pioglitazone (Actos)FDA Link 01/2020 - 01/2019
2	SodiumIBA 01/2020 - 02/2013
2	Messenger RNA (mRNA)IBA 01/2018 - 03/2014
2	sodium-calcium exchanger 1IBA 01/2013 - 11/2009
2	AntiportersIBA 01/2013 - 01/2013
2	Pharmaceutical PreparationsIBA 12/2011 - 05/2005
2	EnzymesIBA 01/2011 - 11/2004
2	Superoxide Dismutase-1IBA 01/2011 - 11/2004
2	EstersIBA 11/2009 - 05/2005
2	Fura-2 (Fura 2)IBA 11/2009 - 05/2005
1	NeurotoxinsIBA 12/2022
1	PhytochemicalsIBA 01/2022
1	Monoterpenes (Monoterpenoids)IBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Volatile Oils (Essential Oils)IBA 06/2021
1	Protective AgentsIBA 06/2021
1	Ion Channels (Ion Channel)IBA 01/2021
1	Sodium Channels (Sodium Channel)IBA 01/2021
1	AcidsIBA 01/2021
1	Dynamins (Dynamin)IBA 01/2019
1	ORAI1 ProteinIBA 01/2019
1	Cyanobacteria ToxinsIBA 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	D-Aspartic Acid (D Aspartate)IBA 01/2019
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	Oleic Acid (Oleate)IBA 01/2018
1	Biological ProductsIBA 01/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 04/2016
1	Calcium-Binding ProteinsIBA 03/2016
1	Calbindin 2IBA 03/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2015
1	Sirtuin 1IBA 11/2015
1	ResveratrolIBA 11/2015
1	5- amino- N- butyl- 2- (4- ethoxyphenoxy)- benzamide hydrochlorideIBA 08/2015
1	Dihydrotachysterol (AT 10)IBA 08/2015
1	LeptinIBA 09/2014
1	N-Methylaspartate (NMDA)IBA 09/2014
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 09/2014
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 03/2014
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 03/2014
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 03/2014
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 12/2013
1	RE1-silencing transcription factorIBA 02/2013
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2013
1	AntibodiesIBA 01/2013
1	7- nitro- 5- phenyl- 1- (pyrrolidin- 1- ylmethyl)- 1H- benzo(e)(1,4)diazepin- 2(3H)- oneIBA 01/2013
1	GliadinIBA 01/2012
1	Carrier Proteins (Binding Protein)IBA 12/2011

Therapy/Procedure

1	Therapeutics 10/2020
1	Denervation 12/2018